NCT03299062View on ClinicalTrials.gov

Smell, Voice and Nasal Swabs as Markers for Neuro-degenerative Disorders

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

November 14, 2017

Primary Completion Date

December 21, 2021

Study Completion Date

December 21, 2021

Conditions
Alzheimer DiseaseNeurodegenerative Diseases
Interventions
DIAGNOSTIC_TEST

Cytology and Immunohistochemistry

Determine if nasal swabs can provide an adequate sample for evaluation using cytology and immunohistochemistry for alpha-synuclein, A-beta and p-tau staining.

Trial Locations (1)

72205

University of Arkansas for Medical Sciences, Little Rock

All Listed Sponsors
lead

University of Arkansas

OTHER

NCT03299062 - Smell, Voice and Nasal Swabs as Markers for Neuro-degenerative Disorders | Biotech Hunter | Biotech Hunter